hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.

hMENA is a key regulator in endothelin-1/β-arrestin1-induced invadopodial function and metastatic process.
复制标题

DOI:
10.1073/pnas.1715998115
复制
发表时间:
2018-03-20
影响因子:
11.1
通讯作者:
Rosanò L
Rosanò L
中科院分区:
综合性期刊1区
文献类型:
--
作者:
Di Modugno F;Caprara V;Chellini L;Tocci P;Spadaro F;Ferrandina G;Sacconi A;Blandino G;Nisticò P;Bagnato A;Rosanò L

文献摘要

参考文献

被引文献

相似文献

发现转移扩散的新靶点和新决定因素是卵巢癌中未满足的需求,卵巢癌受高复发率的困扰。内皮素-1受体(ET-1 R),属于G-蛋白偶联受体家族,是恶性肿瘤进展的重要靶点。在此,我们通过与多功能蛋白β-arrestin 1(β-arr 1)的特异性相互作用,确定了ET-1 R与肌动蛋白调节蛋白hMENA/hMENAΔv6之间的机制联系,β-arr 1启动信号级联反应,作为侵袭足成熟和恶性播散的分子复合物的一部分。通过使用马昔腾坦(一种美国食品药品监督管理局批准的抗肺动脉高压药物)靶向ET-1 R可损害控制卵巢癌进展的β-arr 1介导的信号网络,因此代表了卵巢癌患者的一种治疗选择。内皮素-1受体(ET-1 R)的异常激活可激发与肿瘤进展相关的多效性效应。该受体激活的网络可能是由β-arrestin 1(β-arr 1)驱动的相互作用体精细地、空间地和暂时地协调的。在这里,我们确定hMENA,肌动蛋白调节蛋白ENA/VASP家族的成员,作为β-arr 1的相互作用伴侣,在浆液性卵巢癌(SOC)进展中ET-1 R下游的侵袭足功能所必需。ET-1激活ET-1 R通过β-arr 1上调hMENA/hMENAΔv6亚型的表达,仅限于间充质样侵袭性SOC细胞。β-arr 1与hMENA/hMENAΔv6的相互作用由ET-1触发,导致RhoC和coronin的激活,膜1型基质金属蛋白酶的募集和侵袭伪足的成熟,从而增强细胞可塑性,跨内皮迁移和侵袭细胞的扩散。ET-1 R拮抗剂马昔腾坦给药损害了β-arr 1与hMENA的相互作用,并抑制了SOC原位异种移植物中的侵袭足成熟和肿瘤播散。最后,高ETAR/hMENA/β-arr 1基因表达特征与SOC患者的不良预后相关。这些数据确定了hMENA/hMENAΔv6在ET-1/β-arr 1诱导的侵袭性伪足活性和卵巢癌进展中的关键作用。
Discovering new targets and novel determinants of metastatic spread is an unmet need in ovarian cancer, which is plagued by high rates of recurrence. Endothelin-1 receptors (ET-1R), belonging to the G-protein–coupled receptor family, represent important targets critically involved in malignant progression. Here we identify a mechanistic link between ET-1R and the actin regulatory protein hMENA/hMENAΔv6 through the specific interaction with the multifunctional protein β-arrestin1 (β-arr1), which initiates signaling cascades as part of the molecular complex crucial for invadopodial maturation and malignant dissemination. Targeting ET-1R by using macitentan, a Food and Drug Administration-approved antipulmonary arterial hypertension drug, can impair the β-arr1–mediated signaling network controlling ovarian cancer progression and therefore represents a therapeutic option for ovarian cancer patients. Aberrant activation of endothelin-1 receptors (ET-1R) elicits pleiotropic effects relevant for tumor progression. The network activated by this receptor might be finely, spatially, and temporarily orchestrated by β-arrestin1 (β-arr1)–driven interactome. Here, we identify hMENA, a member of the actin-regulatory protein ENA/VASP family, as an interacting partner of β-arr1, necessary for invadopodial function downstream of ET-1R in serous ovarian cancer (SOC) progression. ET-1R activation by ET-1 up-regulates expression of hMENA/hMENAΔv6 isoforms through β-arr1, restricted to mesenchymal-like invasive SOC cells. The interaction of β-arr1 with hMENA/hMENAΔv6 triggered by ET-1 leads to activation of RhoC and cortactin, recruitment of membrane type 1-matrix metalloprotease, and invadopodia maturation, thereby enhancing cell plasticity, transendothelial migration, and the resulting spread of invasive cells. The treatment with the ET-1R antagonist macitentan impairs the interaction of β-arr1 with hMENA and inhibits invadopodial maturation and tumor dissemination in SOC orthotopic xenografts. Finally, high ETAR/hMENA/β-arr1 gene expression signature is associated with a poor prognosis in SOC patients. These data define a pivotal function of hMENA/hMENAΔv6 for ET-1/β-arr1–induced invadopodial activity and ovarian cancer progression.
DOI: 10.1038/nrm3141
发表时间: 2011-06-23
期刊: Nature reviews. Molecular cell biology
影响因子: --
作者:
通讯作者: --
DOI: 10.1016/s0092-8674(00)81341-0
发表时间: 1996-10-18
期刊: CELL
影响因子: 64.5
作者:
Gertler, FB;Niebuhr, K;Soriano, P
通讯作者: Soriano, P
DOI: 10.1038/onc.2012.527
发表时间: 2013-10-17
期刊: ONCOGENE
影响因子: 8
作者:
Rosano, L.;Cianfrocca, R.;Bagnato, A.
通讯作者: Bagnato, A.
DOI: 10.1016/j.cub.2011.03.039
发表时间: 2011-04-26
期刊: CURRENT BIOLOGY
影响因子: 9.2
作者:
Bravo-Cordero, Jose Javier;Oser, Matthew;Chen, Xiaoming;Eddy, Robert;Hodgson, Louis;Condeelis, John
通讯作者: Condeelis, John
DOI: 10.1080/2162402x.2016.1221556
发表时间: 2016
期刊: Oncoimmunology
影响因子: 7.2
作者:
Melchionna R;Iapicca P;Di Modugno F;Trono P;Sperduti I;Fassan M;Cataldo I;Rusev BC;Lawlor RT;Diodoro MG;Milella M;Grazi GL;Bissell MJ;Scarpa A;Nisticò P
通讯作者: Nisticò P